Detalles de la búsqueda
1.
Intranasal therapeutic vaccine containing HBsAg and HBcAg for patients with chronic hepatitis B; 18 months follow-up results of phase IIa clinical study.
Hepatol Res;
53(3): 196-207, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36399406
2.
Hepatitis B Core-related Antigen: An Alternative to Hepatitis B Virus DNA to Assess Treatment Eligibility in Africa.
Clin Infect Dis;
70(7): 1442-1452, 2020 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-31102406
3.
Prevalence and risk of hepatitis E virus infection in the HIV population of Nepal.
Virol J;
14(1): 228, 2017 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-29162143
4.
Comprehensive analysis of antigenic variations and genomic properties of hepatitis B virus in clinical samples in the mid-north east region of Bangladesh.
Infect Genet Evol;
119: 105572, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38367678
5.
Epidemiological and molecular analyses of a non-seasonal outbreak of acute icteric hepatitis E in Bangladesh.
J Med Virol;
85(8): 1369-76, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23703666
6.
HBsAg, HBcAg, and combined HBsAg/HBcAg-based therapeutic vaccines in treating chronic hepatitis B virus infection.
Hepatobiliary Pancreat Dis Int;
12(4): 363-9, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23924493
7.
A Narrative Review on the Specific Pattern of HBV Genotype in Bangladesh: Clinical Implications for Management.
Euroasian J Hepatogastroenterol;
13(2): 152-158, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38222956
8.
Cellular and Molecular Mechanisms of Pathogenic and Protective Immune Responses to SARS-CoV-2 and Implications of COVID-19 Vaccines.
Vaccines (Basel);
11(3)2023 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36992199
9.
Antiviral Response across Genotypes after Treatment of Chronic Hepatitis B Patients with the Therapeutic Vaccine NASVAC or Pegylated Interferon.
Vaccines (Basel);
11(5)2023 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37243066
10.
Development of Therapy Based on the Exploration of Biological Events Underlying the Pathogenetic Mechanisms of Chronic Hepatitis B Infection.
Biomedicines;
11(7)2023 Jul 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37509583
11.
Safety profile, antiviral capacity, and liver protection of a nasal therapeutic vaccine in patients with chronic hepatitis B: Five-year-follow-up outcomes after the end of treatment.
Front Med (Lausanne);
10: 1032531, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36844221
12.
Intranasal HBsAg/HBcAg-Containing Vaccine Induces Neutralizing Anti-HBs Production in Hepatitis B Vaccine Non-Responders.
Vaccines (Basel);
11(9)2023 Sep 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37766155
13.
Impact of the Route and Schedule of Immunization on the Serological and Virological Response of Chronic Hepatitis B Patients Treated with HeberNasvac.
Euroasian J Hepatogastroenterol;
13(2): 73-78, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38222949
14.
Recent Dengue Infection in Bangladesh: A Seasonal Endemic Progressing to Year-long Serious Health Concern.
Euroasian J Hepatogastroenterol;
13(2): 145-151, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38222961
15.
INASL-SAASL Consensus Statements on NAFLD Name Change to MAFLD.
J Clin Exp Hepatol;
13(3): 518-522, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37250868
16.
Identification of Leading Compounds from Euphorbia neriifolia (Dudsor) Extracts as a Potential Inhibitor of SARS-CoV-2 ACE2-RBDS1 Receptor Complex: An Insight from Molecular Docking ADMET Profiling and MD-simulation Studies.
Euroasian J Hepatogastroenterol;
13(2): 89-107, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38222948
17.
Inter-genotypic recombinant hepatitis C virus strains in Japan noted by discrepancies between immunoassay and sequencing.
J Med Virol;
84(7): 1018-24, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22585717
18.
Biochemical, virological, immunological and histopathological features of 702 incidentally detected chronic hepatitis B virus carriers in Bangladesh.
Digestion;
86(1): 1-5, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22688441
19.
Immune therapies against chronic hepatitis B.
J Gastroenterol;
57(8): 517-528, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35708793
20.
Action Mechanisms and Scientific Rationale of Using Nasal Vaccine (HeberNasvac) for the Treatment of Chronic Hepatitis B.
Vaccines (Basel);
10(12)2022 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36560498